This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02289/identifier/chemspider/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02289/identifier/chebi/
n15http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB02289/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB02289/identifier/pubchem-compound/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/resource/drugbank/drug/DB02289/identifier/pubchem-substance/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02289/identifier/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02289
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n13:DB02289 n15:DB02289
dcterms:title
2-Aminopropanedioic Acid
adms:identifier
n6:100714 n7:46505306 n8:DB02289 n9:FGL n10:17475 n11:90998
n3:IUPAC-Name
n4:271B4F6B-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4F71-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4F70-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4F6D-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4F6E-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4F6F-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4F69-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4F6A-363D-11E5-9242-09173F13E4C5 n4:271B4F67-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4F68-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4F77-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4F78-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4F72-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4F73-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4F75-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4F74-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4F76-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
1068-84-4
n3:Bioavailability
n4:271B4F7D-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4F7F-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4F80-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4F7C-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4F7B-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4F7E-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4F6C-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4F79-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4F7A-363D-11E5-9242-09173F13E4C5